Aruna Bio

[On Demand]
Aruna Bio, Inc., is the leader in the development of neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics capable of revolutionizing the treatment of a range of neurodegenerative disorders such as Parkinson’s, Multiple Sclerosis, as well as Stroke, where significant unmet medical need exists today.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Neural exosome AB126
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Chief Executive Officer
ArunA Bio